Literature DB >> 25192707

Multiple chronic health conditions and their link with wealth assets.

Deborah J Schofield1, Emily J Callander2, Rupendra N Shrestha3, Megan E Passey4, Simon J Kelly5, Richard Percival5.   

Abstract

BACKGROUND: There has been little research on the economic status of those with multiple health conditions, particularly on the relationship between multiple health conditions and wealth. This paper will assess the difference in the value and type of wealth assets held by Australians who have multiple chronic health conditions.
METHODS: Using Health&WealthMOD, a microsimulation model of the 45-64-year-old Australian population in 2009, a counterfactual analysis was undertaken. The actual proportion of people with different numbers of chronic health conditions with any wealth, and the value of this wealth was estimated. This was compared with the counterfactual values had the individuals had no chronic health conditions.
RESULTS: There was no change in the proportion of people with one health condition who actually had any wealth, compared to the counterfactual proportion had they had no chronic health conditions. Ninety-four percent of those with four or more health conditions had some accumulated wealth; however, under the counterfactual, 100% would have had some accumulated wealth. There was little change in the value of non-income-producing assets under the counterfactual, regardless of number of health conditions. Those with four or more chronic health conditions had a mean value of $17 000 in income-producing assets; under the counterfactual, the average would have been $78 000.
CONCLUSION: This study has highlighted the variation in the value of wealth according to number of chronic health conditions, and hence the importance of considering multiple morbidities when discussing the relationship between health and wealth.
© The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25192707     DOI: 10.1093/eurpub/cku134

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  3 in total

1.  Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study.

Authors:  Thunyarat Anothaisintawee; Umaporn Udomsubpayakul; Mark McEvoy; Panuwat Lerdsitthichai; John Attia; Ammarin Thakkinstian
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

2.  Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients.

Authors:  Phisitt Vejakama; Atiporn Ingsathit; Gareth J McKay; Alexander P Maxwell; Mark McEvoy; John Attia; Ammarin Thakkinstian
Journal:  BMC Nephrol       Date:  2017-11-29       Impact factor: 2.388

3.  Medical status of patients presenting for treatment at an Australian dental institute: a cross-sectional study.

Authors:  Agnieszka M Frydrych; Richard Parsons; Omar Kujan
Journal:  BMC Oral Health       Date:  2020-10-21       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.